Foghorn Therapeutics Inc.
NASDAQ:FHTX
Foghorn Therapeutics Inc.
NASDAQ:FHTX
Price:
4.89
USD
0.2%
Market Closed
Market Cap:
$286.4m
Cash Flow Statement
Cash Flow Statement
Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc.
Currency: USD
| Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||||||
| Net Income |
(58)
|
(76)
|
(69)
|
(78)
|
(85)
|
(93)
|
(101)
|
(105)
|
(109)
|
(109)
|
(109)
|
(113)
|
(115)
|
(103)
|
(98)
|
(93)
|
(86)
|
(91)
|
(87)
|
(80)
|
(75)
|
(72)
|
(74)
|
|
| Depreciation & Amortization |
1
|
1
|
1
|
2
|
2
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
|
| Stock-Based Compensation |
3
|
4
|
3
|
4
|
6
|
7
|
8
|
10
|
11
|
13
|
14
|
16
|
17
|
17
|
16
|
15
|
14
|
12
|
12
|
11
|
11
|
11
|
0
|
|
| Other Non-Cash Items |
4
|
7
|
8
|
9
|
11
|
12
|
14
|
16
|
17
|
17
|
18
|
18
|
19
|
20
|
19
|
18
|
19
|
17
|
15
|
15
|
12
|
13
|
17
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
3
|
4
|
4
|
3
|
2
|
1
|
1
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
1
|
1
|
1
|
2
|
1
|
2
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
4
|
22
|
29
|
23
|
22
|
5
|
33
|
331
|
323
|
323
|
282
|
(18)
|
(20)
|
(40)
|
(42)
|
(45)
|
(46)
|
(32)
|
(32)
|
(32)
|
(30)
|
(32)
|
(32)
|
|
| Cash from Operating Activities |
(49)
N/A
|
(46)
+6%
|
(31)
+32%
|
(44)
-39%
|
(50)
-14%
|
(73)
-47%
|
(50)
+31%
|
244
N/A
|
234
-4%
|
234
+0%
|
194
-17%
|
(109)
N/A
|
(112)
-3%
|
(120)
-6%
|
(118)
+1%
|
(116)
+2%
|
(110)
+6%
|
(103)
+6%
|
(100)
+3%
|
(95)
+5%
|
(90)
+5%
|
(88)
+2%
|
(86)
+3%
|
|
| Investing Cash Flow | ||||||||||||||||||||||||
| Capital Expenditures |
(4)
|
(9)
|
(16)
|
(17)
|
(16)
|
(11)
|
(3)
|
(2)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
|
| Other Items |
0
|
0
|
(93)
|
(94)
|
(16)
|
(63)
|
40
|
(118)
|
(321)
|
(227)
|
(243)
|
(54)
|
110
|
102
|
146
|
143
|
85
|
(14)
|
(29)
|
(27)
|
25
|
122
|
112
|
|
| Cash from Investing Activities |
(4)
N/A
|
(9)
-154%
|
(109)
-1 124%
|
(111)
-2%
|
(32)
+71%
|
(74)
-132%
|
36
N/A
|
(120)
N/A
|
(322)
-168%
|
(228)
+29%
|
(244)
-7%
|
(55)
+77%
|
108
N/A
|
101
-7%
|
144
+44%
|
142
-2%
|
85
-40%
|
(15)
N/A
|
(30)
-101%
|
(28)
+8%
|
24
N/A
|
121
+400%
|
112
-7%
|
|
| Financing Cash Flow | ||||||||||||||||||||||||
| Net Issuance of Common Stock |
49
|
91
|
213
|
213
|
165
|
123
|
1
|
2
|
3
|
2
|
2
|
2
|
1
|
2
|
2
|
3
|
106
|
106
|
106
|
105
|
2
|
0
|
1
|
|
| Net Issuance of Debt |
0
|
8
|
4
|
0
|
0
|
5
|
(21)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
0
|
(1)
|
0
|
0
|
0
|
0
|
42
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(1)
|
0
|
(0)
|
0
|
0
|
|
| Cash from Financing Activities |
57
N/A
|
98
+72%
|
218
+123%
|
217
0%
|
170
-22%
|
129
-24%
|
22
-83%
|
23
+1%
|
24
+4%
|
23
-1%
|
2
-92%
|
2
-17%
|
1
-60%
|
2
+183%
|
2
+5%
|
3
+60%
|
106
+3 624%
|
106
0%
|
105
0%
|
104
-1%
|
1
-99%
|
0
-69%
|
1
+129%
|
|
| Change in Cash | ||||||||||||||||||||||||
| Net Change in Cash |
5
N/A
|
43
+830%
|
77
+81%
|
63
-19%
|
88
+41%
|
(17)
N/A
|
8
N/A
|
147
+1 672%
|
(64)
N/A
|
30
N/A
|
(49)
N/A
|
(163)
-233%
|
(4)
+98%
|
(17)
-391%
|
28
N/A
|
29
+2%
|
81
+184%
|
(13)
N/A
|
(25)
-97%
|
(18)
+27%
|
(65)
-256%
|
33
N/A
|
27
-19%
|
|
| Free Cash Flow | ||||||||||||||||||||||||
| Free Cash Flow |
(52)
N/A
|
(55)
-5%
|
(48)
+13%
|
(61)
-28%
|
(65)
-8%
|
(84)
-28%
|
(54)
+36%
|
243
N/A
|
233
-4%
|
233
+0%
|
192
-18%
|
(111)
N/A
|
(114)
-3%
|
(121)
-6%
|
(119)
+1%
|
(117)
+2%
|
(110)
+6%
|
(104)
+5%
|
(101)
+2%
|
(96)
+5%
|
(91)
+5%
|
(89)
+3%
|
(86)
+3%
|
|
Switch to:
Switch to:
See Also
Discover More
